Wilborn TW, Timpe EM, Wu-Pong S, et al. Factors influencing faculty perceptions of workload equity. Curr Pharm Teaching and Learning. 2013; 5:9-13.

Iranikhah M, Wilborn TW, Wensel TM. Denosumab for the treatment of skeletal related events in patients with bone metastasis. Pharmacotherapy. 2012; 32:274-84.

Wensel TM, Iranikhah MM, Wilborn TW. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. Pharmacotherapy. 2011; 31:510-23.

Cruthirds D, Cretton-Scott E, Wilborn T, Monk-Tutor M, Nelson A. Biochemistry and pathophysiology instruction in US colleges and schools of pharmacy: Faculty and course characteristics and faculty perceptions of student preparedness. Curr Pharm Teaching and Learning. 2011; 3:137-147.

Falany CN, He D, Li L, Falany JL, Wilborn TW, Kocarek TA, Runge-Morris. Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in Cystic Fibrosis. J Steroid Biochem Mol Biol. 2009; 111:113-9.

Li L, He D, Wilborn TW, Falany JL, Falany CN. Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation. Steroids. 2009; 74: 20-29.

He D, Wilborn TW, Falany JL. Li L, Falany CN. Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes. Biochem Biophys Acta. 2008; 1783: 2391-2397.

Wilborn TW, Lang NP, Smith M, Meleth F, Falany CN. Association of SULT2A1 allelic variants with plasma adrenal androgens and prostate cancer in African American men. J Steroid Biochem Mol Biol. 2006; 99:209-14.

Wilborn TW, Schafer JA. Expression of multiple alpha-adrenoceptor isoforms in rat CCD. Am J Physiol. 1998; 275:111-8.